Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patientsEun‐Jung Jung, George A. Călin, Ju‐Yeon Kim et al.|Cancer|2011Cited by 291
Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT SignalingXiao‐Feng Le, Robert C. Bast|Journal of Biological Chemistry|2004Cited by 71
Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast CancerXiao‐Feng Le, Robert C. Bast|PLoS ONE|2012Cited by 66